Rapid response Publications

Drug Therapies for COVID-19

Tuesday, 19 April, 2022

Research studies involving thousands of people have allowed scientists to test which drugs are effective at treating COVID-19. Several drug therapies are now available to treat people who are in hospital with COVID-19, or to prevent infections in vulnerable people becoming more serious. This briefing explains which drugs are available, the groups of people in which they are used and how they work. It also outlines the importance of monitoring the emergence of new variants and drug resistance.

The future of COVID-19 vaccines

Thursday, 31 March, 2022

A new generation of COVID-19 vaccines could support vaccination strategies in the long term. But what are the latest developments from preclinical and clinical trials?

COVID-19: Omicron, recent developments, and the likely impact of future variants on the pandemic

Monday, 07 March, 2022

The Omicron variant of the SARS-CoV-2 virus, which causes COVID-19, has been found across the world since it was first detected in early November 2021. This article describes the characteristics of the variant and its health impacts. It also discusses vaccine effectiveness against the variant and the medium and long-term outlook for the future course of the pandemic.

COVID-19: Omicron, recent developments, and the likely impact of future variants on the pandemic

Rapid response

Addressing COVID-19 in the long-term – the role of immunisation

Thursday, 24 February, 2022

Immunisation strategies are one of the key elements to addressing the impacts of SARS-CoV-2 in the short- and long-term. What are the key factors to consider when developing long-term immunisation strategies? What are the key unknowns and how can they be addressed?
Rapid response

Long COVID: The long-term health effects of COVID-19

Friday, 17 December, 2021

What is Long COVID ? How many people are affected? What are the key challenges for diagnosis and treatment? What are the priority areas for research?
Rapid response

COVID-19: The Omicron Variant

Friday, 03 December, 2021

The Omicron variant of the SARS-CoV-2 virus, which causes COVID-19, has been found across the world since it was first detected in early November 2021. This article describes the characteristics of the variant, why scientists are concerned, and the possible impact that it might have on the course of the pandemic.
Rapid response

Impact of COVID-19 on Early Childhood Education & Care

Wednesday, 27 October, 2021

This rapid response presents current research on the impact of the pandemic on the ECEC sector in England and the impact of changes in access to ECEC on pre-school children.
Rapid response

Water fluoridation and dental health

Wednesday, 25 August, 2021

An overview of water fluoridation in England, including the impact of fluoride on dental health, an overview of dental health in England, and the importance and implications of dental health inequalities.
- Rapid response
- Health and social care
Rapid response

Immunising children against COVID-19

Thursday, 29 July, 2021

As the UK COVID-19 immunisation programme reaches all adults, the Government has announced an update to its policy on using a COVID-19 vaccine in children. So, how does COVID-19 affect children? What will the impact of vaccinating children be on preventing disease and minimising associated risks? And what do we know about public attitudes to using COVID-19 vaccines in children?
Rapid response

How does the virus that causes COVID-19 spread?

Friday, 16 July, 2021

What are the different mechanisms by which the novel SARS-CoV-2 coronavirus is transmitted from one person to another, how has the scientific thinking changed, and how can transmission be reduced?
Rapid response

COVID-19 vaccine coverage and targeted interventions to improve vaccination uptake

Friday, 02 July, 2021

The COVID-19 vaccination programme launched in January 2021. All adults over 18 have now been offered the vaccine, although it was reported that 1.3 million people who had been offered a vaccine had not received it. Some people are vaccine hesitant whilst others experience barriers to accessing vaccines. Targeted interventions have been promoted locally and nationally to improve vaccine uptake.
Rapid response

COVID-19 vaccines: effectiveness against the B.1.617.2 variant and latest updates from trials

Wednesday, 26 May, 2021

The B.1.617.2 variant was first observed in India and is rapidly spreading in the UK. What is known about effectiveness of vaccines against this variant - and how close to the finish line are the other vaccines already secured by the UK?
Rapid response

What is the real-world impact of COVID-19 vaccines on community transmission?

Tuesday, 25 May, 2021

Real-world data shows that COVID-19 vaccines deployed in the UK are effective in protecting against SARS-CoV-2 transmission already after a single dose. Are all the other COVID-19 vaccines equally effective? What is the evidence on balancing between vaccinations and lifting restrictions?
Rapid response

COVID-19 vaccines safety and blood clots

Wednesday, 19 May, 2021

The safety of COVID-19 vaccines currently deployed in the UK is closely monitored. This monitoring has shown that the University of Oxford/AstraZeneca vaccine is associated with very rare blood clots. What is known about these very rare adverse events?
Rapid response

COVID-19 vaccine misinformation

Monday, 26 April, 2021

There have been large volumes of inaccurate information about COVID-19 circulating since the beginning of the pandemic, including misinformation about vaccinations against the infection. This article looks at the types and sources of COVID-19 vaccine misinformation and its public health impact. It also looks at the different approaches being used to fight COVID-19 vaccine misinformation, such as social media content moderation and guidance for the public.

Total results (page 1 of 5)